(S)he said what!?

On November 22, J&J/Janssen Cilags’ SGLT-2 inhibitor Invokana (canagliflozin) was approved in Europe. This makes Invokana the second SGLT-2 inhibitor approved in...

On April 15, the FDA approved GlaxoSmithKline’s once-weekly GLP-1 agonist Tanzeum (albiglutide) for type 2 diabetes, which makes it the second once-weekly GLP-1 agonist...

Are all carbs created equal? Adam learns why 30 grams of carbs is NOT always 30 grams of carbs…

At the recent 2013 European Association for the Study of Diabetes (EASD) conference, Abbott debuted a new diabetes technology category called Flash Glucose Monitoring...

On January 21, Glooko and Joslin announced a partnership to develop a new web/mobile-based diabetes management platform. The system will combine a “Virtual Joslin”...

On March 25, Lilly and Boehringer Ingelheim (BI) announced that they submitted an application to the FDA for empagliflozin, an SGLT-2 inhibitor, for type 2 diabetes...

On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza...

(S)he said what!?

On October 14, Cellnovo announced the start of a usability study of its mobile-enabled insulin pump in the UK. The trial will essentially study how patients like using...

On March 3, AstraZeneca announced FDA approval for the Bydureon dual-chambered pen (once-weekly exenatide) to improve glycemic control in people with type 2. The device...

(S)he said what!?

In May 2013, Jawbone announced the acquisition of BodyMedia and the launch of a new app platform for its UP health wristband , which tracks movement and sleep and syncs...

LifeScan’s OneTouch VerioSync meter – the magic of wireless blood glucose data to your iPhone/iPod/iPad.

On November 25, the FDA announced the removal of the major restrictions on the prescription and use of GlaxoSmithKline’s Avandia (rosiglitazone) for type 2 diabetes...

In a live online chat on March 31, highly-regarded FDA Director Dr. Courtney Lias and patient advocate Bennet Dunlap, founder of Strip Safely discussed the new blood...

The challenges and triumphs of providing high quality diabetes care in low-income communities.

On August 23, the American Association of Clinical Endocrinologists (AACE) announced that it will hold a consensus conference on obesity called “Building an Evidence...

Inspiring non-profit Insulindependence recently launched a member search feature that allows users to search for other people with diabetes in their area with similar...

On April 16, Vivus announced that the FDA approved a change to the distribution of Qsymia . Qsymia is a weight loss and weight management drug that is designed to be...